Covered recipient · General Payments record
SOPHIA TAMAYO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$690.35
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $690.35 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $266.43 | 3 |
| Janssen Pharmaceuticals, Inc | $147.62 | 2 |
| Acerta Pharma LLC | $125.00 | 1 |
| Amgen Inc. | $105.62 | 1 |
| ITI, Inc. | $30.88 | 1 |
| ABBVIE INC. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $690.35 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.80 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108284239 | CMS |
| Amgen Inc. | $105.62 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117395724 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104389845 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30.88 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143613486 | CMS |
| Janssen Pharmaceuticals, Inc | $119.48 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078238881 | CMS |
| Janssen Pharmaceuticals, Inc | $28.14 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078238831 | CMS |
| Novo Nordisk Inc | $124.99 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100642612 | CMS |
| Novo Nordisk Inc | $20.65 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289912 | CMS |
| Novo Nordisk Inc | $120.79 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100413244 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.